Economic evaluation and costs of remote patient monitoring for cardiovascular disease in the United States: a systematic review

Abstract

Background Remote patient monitoring (RPM) has emerged as a viable and valuable care delivery method to improve chronic disease management. In light of the high prevalence and substantial economic burden of cardiovascular disease (CVD), this systematic review examines the cost and cost-effectiveness of using RPM to manage CVD in the United States. Methods We systematically searched databases to identify potentially relevant research. Findings were synthesized for cost and cost-effectiveness by economic study type with consideration of study perspective, intervention, clinical outcome, and time horizon. The methodological quality was assessed using the Joanna Briggs Institute Checklist for Economic Evaluations. Results Thirteen articles with fourteen studies published between 2011 and 2021 were included in the final review. Studies from the provider perspective with a narrow scope of cost components identified higher costs and similar effectiveness for the RPM group relative to the usual care group. However, studies from payer and healthcare sector perspectives indicate better clinical effectiveness of RPM relative to usual care, with two cost-utility analysis studies suggesting that RPM relative to usual care is a cost-effective tool for CVD management even at the conservative $50,000 per Quality-Adjusted Life-Year threshold. Additionally, all model-based studies revealed that RPM is cost-effective in the long run. Conclusions Full economic evaluations identified RPM as a potentially cost-effective tool, particularly for long-term CVD management. In addition to the current literature, rigorous economic analysis with a broader perspective is needed in evaluating the value and economic sustainability of RPM.

Bottom-Up Analysis of Telemonitoring Costs: A Case Study in Slovenian Primary Care

“…This was deemed essential for ethical reasons, given the study population's various associated health conditions. However, a more restrictive approach might prove feasible and efficient in younger populations with isolated AH or T2D (17)(18)(19).…”

Preventative Sensor-Based Remote Monitoring of the Diabetic Foot in Clinical Practice

“…RPM has been applied to other chronic disease states, showing early promise in improving outcomes in patients with obstructive pulmonary disease, Parkinson’s disease, hypertension, and other cardiovascular diseases (CVD) [ 25 , 26 ]. The American Heart Association published a position statement providing guidance on RPM implementation to encourage its use to improve CVD outcomes, and systematic reviews examining cardiovascular applications of RPM suggest longer-term cost effectiveness of such approaches [ 27 , 28 ].…”